安徽安科生物工程（集团）股份有限公司关于回购注销部分限制性股票减资暨通知债权人的公告

Core Points - The company announced the repurchase and cancellation of a total of 924,050 restricted stocks due to unmet vesting conditions for certain employees under its third-phase incentive plan [1][2] - The repurchase will lead to a reduction in the company's total share capital and registered capital by 924,050 shares and 924,050.00 yuan respectively, pending approval from the shareholders' meeting [2][3] Group 1: Repurchase Details - The company will repurchase 30,400 restricted stocks from the oncology division and 893,650 restricted stocks from other divisions that have not met the vesting conditions [1] - The repurchase and cancellation of these stocks will require the company to follow the procedures set by the Shenzhen Stock Exchange and the China Securities Depository and Clearing Corporation [2] Group 2: Creditor Notification - Creditors are informed that they have 45 days from the announcement date to claim their debts or request guarantees, as the repurchase will reduce the registered capital [3] - Creditors must provide valid documentation to support their claims, including contracts and identification [3][4] Group 3: Claim Submission Process - The claim submission address is provided, along with the timeline for submissions, which starts from November 26, 2024, for 45 days [4] - Contact information for the company's securities affairs department is included for any inquiries related to the claims [5]